Core Scientific (NASDAQ:CORZ) Raised to Strong-Buy at Zacks Research

Posted by George Bondi on Nov 12th, 2026

Core Scientific (NASDAQ:CORZ – Get Free Report) was upgraded by Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday, Zacks reports.

CORZ has been the topic of several other reports. Keefe, Bruyette & Woods raised Core Scientific from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $25.00 to $28.00 in a report on Thursday, July 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a research report on Thursday, October 15th. Needham & Company LLC dropped their price target on Core Scientific from $35.00 to $28.00 and set a “buy” rating for the company in a report on Friday, November 6th. Citigroup reiterated a “market outperform” rating on shares of Core Scientific in a research report on Tuesday. Finally, Craig Hallum reissued a “buy” rating and issued a $25.00 price objective on shares of Core Scientific in a research note on Friday, November 6th. Three analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $30.32.

View Our Latest Research Report on Core Scientific

Core Scientific Stock Up 11.0%

Shares of Core Scientific stock opened at $14.57 on Tuesday. The stock has a market capitalization of $4.70 billion, a P/E ratio of -4.17 and a beta of 5.56. The company has a 50-day simple moving average of $15.51 and a 200 day simple moving average of $19.41. Core Scientific has a 12-month low of $10.59 and a 12-month high of $30.46.

Core Scientific (NASDAQ:CORZ – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.52. The firm had revenue of $232.87 million during the quarter, compared to the consensus estimate of $196.54 million. Core Scientific had a negative net margin of 18.31% and a negative return on equity of 70.05%. On average, equities analysts anticipate that Core Scientific will post 0.08 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Todd DuChene sold 10,000 shares of the stock in a transaction that occurred on Monday, October 26th. The shares were sold at an average price of $13.56, for a total transaction of $135,600.00. Following the sale, the insider directly owned 1,133,286 shares of the company’s stock, valued at $15,367,358.16. This represents a 0.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Eric Weiss purchased 7,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were bought at an average cost of $19.19 per share, for a total transaction of $134,330.00. Following the completion of the purchase, the director directly owned 259,262 shares of the company’s stock, valued at $4,975,237.78. The trade was a 2.77% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have bought 19,000 shares of company stock worth $342,290 and have sold 90,000 shares worth $1,428,900. 1.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CORZ. BlackRock Inc. acquired a new position in shares of Core Scientific during the second quarter valued at $719,649,000. Apollo Management Holdings L.P. acquired a new stake in Core Scientific in the second quarter worth about $115,671,000. Avala Global LP acquired a new stake in Core Scientific in the second quarter worth about $101,729,000. Bank of America Corp DE increased its position in Core Scientific by 412.5% in the first quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock worth $71,903,000 after purchasing an additional 3,868,535 shares during the period. Finally, Cooper Creek Partners Management LLC bought a new stake in Core Scientific during the 1st quarter worth about $37,407,000.

About Core Scientific

(Get Free Report)

Core Scientific, Inc. is a U.S.-based digital infrastructure company that operates data centers and provides computing services. Its business includes mining bitcoin, which involves using specialized computers to help process transactions and secure the Bitcoin network, as well as hosting equipment for third-party mining customers. The company also provides data center infrastructure for high-performance computing workloads, including artificial intelligence applications. Its facilities and services are designed to support the power, cooling, and computing needs of these operations.